Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
7 Stocks Under $50 to Buy and Hold Forever
12:42pm, Wednesday, 12'th Oct 2022
While several stocks under $50 to buy exist in the equities sector, which ones are worthwhile to hold onto forever? Identifying these picks in an unenviable task.
LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
09:45am, Thursday, 08'th Sep 2022
We reiterate the buy call on LeMaitre Vascular. The company's capital management strategies continue to yield double-digit ROI from its invested capital.
LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
03:04pm, Wednesday, 31'st Aug 2022
BURLINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in a fireside chat at the Morgan Stanley 20th
ZBH vs. LMAT: Which Stock Should Value Investors Buy Now?
12:47pm, Friday, 05'th Aug 2022
ZBH vs. LMAT: Which Stock Is the Better Value Option?
LeMaitre to Present at the Canaccord Genuity 42nd Annual Growth Conference
04:25pm, Monday, 01'st Aug 2022
BURLINGTON, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annua
LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q2 2022 Results - Earnings Call Transcript
06:07pm, Saturday, 30'th Jul 2022
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2022 Earnings Conference Call July 28, 2022 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Exe
LeMaitre Vascular (LMAT) Lags Q2 Earnings Estimates
07:30pm, Thursday, 28'th Jul 2022
LeMaitre (LMAT) delivered earnings and revenue surprises of -9.38% and 2.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
A Debt-Free and Fairly Valued Medical Devices Company
02:42pm, Wednesday, 20'th Jul 2022
LeMaitre Vascular Inc. ( LMAT , Financial) has been on a roll—it has generated robust financial results and metrics that produced a high GF Score. But the share price has been in a slump.
LeMaitre Vascular: 16% Return Objective From Idiosyncratic Risk Premia
11:03am, Friday, 24'th Jun 2022
LeMaitre has been beaten down lately, however, the pullback lends significant opportunity to add to a long-term compounder. The company has a differentiated value proposition from an investment perspe
LeMaitre to Present at the Sidoti Summer Small Cap Virtual Conference
02:39pm, Friday, 03'rd Jun 2022
BURLINGTON, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Sidoti Summer Small Cap Virtual Conference
LeMaitre to Present at Upcoming Investor Conferences
04:58pm, Monday, 16'th May 2022
BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.
LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q1 2022 Results - Earnings Call Transcript
01:01pm, Saturday, 30'th Apr 2022
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q1 2022 Earnings Conference Call April 28, 2022 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Ex
LeMaitre Vascular (LMAT) Q1 Earnings Miss Estimates
07:35pm, Thursday, 28'th Apr 2022
LeMaitre (LMAT) delivered earnings and revenue surprises of -3.57% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Vascular: Steady As She Goes
10:16am, Thursday, 07'th Apr 2022
LeMaitre Vascular continues to be a solid secular growth play in the vascular business.
Is This Overlooked Stock a Buy After Its Dividend Hike?
10:45am, Saturday, 02'nd Apr 2022
LeMaitre Vascular could be a hidden gem for dividend growth investors.
